The Research and Treatment Interest Group’s remit is deep and broad: across the spectrum of development, from basic research through to clinical trials; across a wide range of topics, including data sharing, crucial medicines, psycho-social standards, and survivorship; and across the country and around the world.
Most importantly, that research investment represents a shared aim to find cures for all types of childhood cancer. CAC2 celebrates each and every member’s efforts to help close the large and persistent gap between funding needs to achieve this goal and available resources.
CAC2 doesn’t just applaud our member’s individual efforts but strives to act as a catalyst for research members to work collaboratively to effect positive change in the childhood cancer research community.
Hosting educational conferences and webinars across a multi-disciplinary childhood cancer research audience to encourage exchange of information and build relationships.
Providing the infrastructure and settings for member organizations to explore for co-funding research projects.
Developing online repositories for childhood cancer research progress including:
Establishing the Ethics Think Tank Working Group to help identify best practices and potential ethical issues associated with pediatric cancer charities that fund researchers and the relationships between those organizations and the research recipients.
Assorted News from the Last Week: CAC2 Individual Member Laura DeKraker Lang-Ree provides a crucial look at self-advocacy for children and families with cancer in
Childhood cancer survivor and parent advocating at a medical appointment By Laura DeKraker Lang-Ree, childhood cancer advocate, speaker, and bestselling author of The Cancer Parent’s
Assorted News from the Last Week: Over the past year, CAC2 supporting organization member LifeArc has hosted a series of workshops to discuss the latest
